Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.

@article{Bekpinar2005CardiovascularRA,
  title={Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.},
  author={Seldağ Bekpinar and Yeşim Unl{\"u}çerçi and S Genc and Aydin T{\"u}rkmen},
  journal={Advances in peritoneal dialysis. Conference on Peritoneal Dialysis},
  year={2005},
  volume={21},
  pages={80-4}
}
In the present study, we used high sensitivity C-reactive protein (hs-CRP) analysis in combination with lipid screening [which has been reported to be a more valuable risk marker than other novel markers such as homocysteine (Hcy) and lipoprotein a] to perform cardiovascular risk assessment in peritoneal dialysis (PD) and hemodialysis (HD) patients. We selected 9 PD patients, 10 HD patients, and 9 control subjects for the study. In those patients, we determined levels of serum lipids, hs-CRP… CONTINUE READING